List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 107 studies with search of: Abacavir sulfate/Lamivudine OR Epzicom[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
2 Recruiting Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
3 Unknown † Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
4 Completed A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Lexiva + Norvir + Epzicom;   Drug: Sustiva + Epzicom
5 Completed Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: tenofovir/emtricitabine;   Drug: Abacavir(ABC)/Lamivudine(3TC)
6 Completed Pharmacokinetic Study Of EPZICOM Tablet
Condition: HIV Infection
Intervention: Drug: Lamivudine / Abacavir Sulfate
7 Active, not recruiting Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
8 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
9 Unknown † A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
Condition: HIV
Interventions: Drug: fos-amprenavir calcium, ritonavir;   Drug: abacavir/lamivudine as Epzicom
10 Completed
Has Results 		Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
11 Completed A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg - Tenofovir 300mg;   Drug: Abacavir 600mg - Lamivudine 300mg
12 Recruiting Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir; Abacavir/Lamivudine
13 Not yet recruiting Study of Options for Second-Line Effective Combination Therapy (SELECT)
Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Abacavir/lamivudine/zidovudine;   Drug: Abacavir/lamivudine;   Drug: Lamivudine/zidovudine;   Drug: Abacavir;   Drug: Zidovudine;   Drug: Lamivudine
14 Unknown † Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Condition: HIV Infection
Interventions: Drug: atazanavir arm;   Drug: efavirenz
15 Active, not recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Conditions: Birth Defects;   HIV Infections
Intervention: Drug: Any Antiretroviral Therapy
16 Completed ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada + Kaletra;   Drug: Kivexa + Kaletra
17 Completed
Has Results 		Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
18 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
19 Unknown † A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
Condition: AIDS-Related Kaposi's Sarcoma
Interventions: Drug: abacavir/3TC/zidovudine;   Drug: abacavir /3TC plus ritonavir boosted lopinavir
20 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services